Barrios V - Search Results

1

The natriuretic effect of nifedipine gastrointestinal therapeutic system remains despite the presence of mild-to-moderate renal failure.

Campo C, Garcia-Vallejo O, Barrios V, Lahera V, Manero M, Esteban E, Rodicio JL, Ruilope LM. Campo C, et al. Among authors: barrios v. J Hypertens. 1997 Dec;15(12 Pt 2):1803-8. doi: 10.1097/00004872-199715120-00093. J Hypertens. 1997. PMID: 9488243 Clinical Trial.

2

Renal implications of the renin-angiotensin-aldosterone system blockade in heart failure.

Ruilope LM, Barrios V, Volpe M. Ruilope LM, et al. Among authors: barrios v. J Hypertens. 2000 Nov;18(11):1545-51. doi: 10.1097/00004872-200018110-00003. J Hypertens. 2000. PMID: 11081765 Review.

3

Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK study.

Barrios V, Escobar C, Calderón A, Echarri R, González-Pedel V, Ruilope LM; CONTROLRISK Investigators. Barrios V, et al. J Hum Hypertens. 2007 Jun;21(6):479-85. doi: 10.1038/sj.jhh.1002167. Epub 2007 Feb 22. J Hum Hypertens. 2007. PMID: 17314997 Clinical Trial.

4

Renal dysfunction and heart failure.

Escobar C, Echarri R, Barrios V. Escobar C, et al. Among authors: barrios v. Panminerva Med. 2010 Mar;52(1):67-78. Panminerva Med. 2010. PMID: 20228727 Review.

5

High doses of lercanidipine are better tolerated than other dihydropyridines in hypertensive patients with metabolic syndrome: results from the TOLERANCE study.

Barrios V, Escobar C, de la Figuera M, Honorato J, Llisterri JL, Segura J, Calderón A. Barrios V, et al. Int J Clin Pract. 2008 May;62(5):723-8. doi: 10.1111/j.1742-1241.2008.01736.x. Epub 2008 Mar 17. Int J Clin Pract. 2008. PMID: 18355238 Free PMC article. Clinical Trial.

6

[Changes in therapeutic targets and level of control of arterial hypertension: New evidence].

Escobar C, Abad-Cardiel M, Prieto MA, de la Figuera M, Barrios V, Segura J. Escobar C, et al. Among authors: barrios v. Hipertens Riesgo Vasc. 2016 Apr-Jun;33(2):63-8. doi: 10.1016/j.hipert.2016.01.002. Epub 2016 Feb 5. Hipertens Riesgo Vasc. 2016. PMID: 26857088 Spanish. No abstract available.

7

Lercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: The LAURA study.

Barrios V, Escobar C, Navarro A, Barrios L, Navarro-Cid J, Calderón A; LAURA Investigators. Barrios V, et al. Among authors: barrios l. Int J Clin Pract. 2006 Nov;60(11):1364-70. doi: 10.1111/j.1742-1241.2006.01176.x. Int J Clin Pract. 2006. PMID: 17073834 Free PMC article.

8

[Improvement in diastolic function in hypertensive patients with left ventricular hypertrophy with inhibitors of the angiotensin converting enzyme].

Sagastagoitia JD, Morillas M, Martínez A, Lage E, Pallarés C, Ugartemendía C, Asín E, Barrios V, Julia J, Sánchez P, Calvo C, González J, Piña C, García-Barbal J, Arnau C. Sagastagoitia JD, et al. Among authors: barrios v. Rev Clin Esp. 1998 Jan;198(1):15-22. Rev Clin Esp. 1998. PMID: 9580230 Clinical Trial. Spanish.

9

[Tolerability and efficiency of a new transdermic nitroglycerin patch in outpatients with chronic stable angina. The PATRICH Trial].

Barrios V, Fernández E, Campuzano R, Peña G; PATRICH study group. Barrios V, et al. Rev Clin Esp. 2002 Jul;202(7):379-84. doi: 10.1016/s0014-2565(02)71085-0. Rev Clin Esp. 2002. PMID: 12139821 Clinical Trial. Spanish.

10

Diabetes and hypertension. What is new?

Barrios V, Escobar C. Barrios V, et al. Minerva Cardioangiol. 2009 Dec;57(6):705-22. Minerva Cardioangiol. 2009. PMID: 19942843 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

523 results

Search Page

Filters